Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

CytoDyn Announces Treatment of First Patient in Pivotal Phase 3 Trial for Critically Ill – KULR-8,

This new pivotal Phase 3 clinical trial (CD16) will focus on hospitalized critically ill COVID-19 patients who require mechanical and invasive …, This new pivotal Phase 3 clinical trial (CD16) will focus on hospitalized critically ill COVID-19 patients who require mechanical and invasive …, Read More

Scroll to Top